Jobs / United States / Glaxosmithkline LLC

Glaxosmithkline LLC

VP & Global Medical Lead, Immunology (Allergy)

2 Locations Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

LeadershipTranslationPatient care

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Glaxosmithkline LLC paid sponsored hires in similar roles8 certified filings for “Principal Scientist” (Medical Scientists, Except Epidemiologists) in PA: $98k–$110k, median $98k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Glaxosmithkline LLC paid sponsored hires in similar roles
8 certified filings for “Principal Scientist” (Medical Scientists, Except Epidemiologists) in PA: $98k–$110k, median $98k. Most were filed at wage level I (63%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Job Purpose The VP, Global Medical Lead (GML) Food Allergy is a key senior business leadership role, reporting to the VP Global Medical Affairs, Immunology, and is a key member of GSK’s Global Medical Affairs, Immunology Leadership Team. The GML will have full responsibility for the Global Medical Strategy for Allergy. The GML will lead the translation of our science to shape the practice of medicine and specialty care to deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies. The role will be accountable for the Medical strategic direction of Allergy and the matrix leadership of the Global Asset Medical Leadership Team, integrating innovative strategies that advance patient care and help shape the practice of medicine. The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/specialty care development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients. In addition to leading the Global Allergy Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Medicines/Immunology Development Team and the Medicine/Immunology Commercial Team where they will provide Medical insight and expertise to inform and influence evidence generation and scientific communication plans across the lifecycle to optimize patient impact within markets A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms. Key Responsibilities ·        Lead both the cross-functional product medical team (PMT) and product development at the Global level ·        As convenor and chair of the PMT • • Jointly accountable for developing the global medical brand strategy and plans for Allergy • Set direction along strategic framework of the medical brand plan including setting scientific objectives, owning the medical scientific narrative and the integrated communication plan • Accountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global operations team and Global data team • Represent medical in cross-functional strategy meetings and workshops, and proactively offer options for innovative medical strategy for the Integrated Asset Plan (IAP) at the Product Development Team (PDT) and Product Commercial Team (PCT) meetings • Provide focused support at key inflection points during development (e.g., launch) ·        As Lead of PMT and medical product team at Global level • • Responsible for representing the voice of the Chief Patient Officer (CPO) Organization for Allergy • Accountable for all medical activities related to product development at the global level • Lead, coach, and mentor direct reports that support the PMT in development of medical brand strategy and plans, and execute and/or support execution of global tactics • Address broader holistic disease area considerations as they arise by convening other relevant PMLs ad-hoc   Enterprise Leadership • Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation). • Act as a partner to the Development and Commercial Lead, ensure integrated and thoughtful insights from across a diverse stakeholder set contribute to shaping the medicines vision, development strategy and clinical development in the early phases of development, and for refining med

Apply on employer site ↗